JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure
H Tsutsui, T Ide, H Ito, Y Kihara, K Kinugawa… - Circulation …, 2021 - jstage.jst.go.jp
After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …
were approved and important evidence for pharmacologic therapy and nonpharmacologic …
Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update
The vascular endothelium is a dynamic, functionally complex organ, modulating multiple
biological processes, including vascular tone and permeability, inflammatory responses …
biological processes, including vascular tone and permeability, inflammatory responses …
JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure―digest version―
H Tsutsui, M Isobe, H Ito, K Okumura, M Ono… - Circulation …, 2019 - jstage.jst.go.jp
Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …
collaborators involved in the previous versions of the heart failure guidelines and members …
On the clinical pharmacology of reactive oxygen species
Reactive oxygen species (ROS) have been correlated with almost every human disease. Yet
clinical exploitation of these hypotheses by pharmacological modulation of ROS has been …
clinical exploitation of these hypotheses by pharmacological modulation of ROS has been …
Gaseous O2, NO, and CO in Signal Transduction: Structure and Function Relationships of Heme-Based Gas Sensors and Heme-Redox Sensors
T Shimizu, D Huang, F Yan, M Stranava… - Chemical …, 2015 - ACS Publications
The heme iron complex is one of the most important cofactors in biological systems (Figure
1). The major functions of the heme iron complex are to serve as the O2 binding site for …
1). The major functions of the heme iron complex are to serve as the O2 binding site for …
Nitric-oxide-modulatory materials for biomedical applications
Conspectus Nitric oxide (NO) is an endogenous signaling molecule that participates in
various physiological and biological pathways associated with vasodilation, immune …
various physiological and biological pathways associated with vasodilation, immune …
The footprint of kynurenine pathway in cardiovascular diseases
M Ala, SP Eftekhar - International Journal of Tryptophan …, 2022 - journals.sagepub.com
Kynurenine pathway is the main route of tryptophan metabolism and produces several
metabolites with various biologic properties. It has been uncovered that several …
metabolites with various biologic properties. It has been uncovered that several …
Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines
H Tsutsui - Pharmacology & Therapeutics, 2022 - Elsevier
Heart failure (HF) is a clinical syndrome with symptoms and or signs caused by a structural
and/or functional cardiac abnormality and associated with elevated natriuretic peptide levels …
and/or functional cardiac abnormality and associated with elevated natriuretic peptide levels …
[HTML][HTML] Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence
Highlights•Chronic kidney disease therapies can be unsuccessful—new options are
needed.•NO deficiency is implicated in CKD pathogenesis, and sGC catalyzes cGMP …
needed.•NO deficiency is implicated in CKD pathogenesis, and sGC catalyzes cGMP …
Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
A Dasgupta, L Bowman, CL D'Arsigny… - Clinical …, 2015 - Wiley Online Library
Nitric oxide (NO) activates soluble guanylate cyclase (sGC) by binding its prosthetic heme
group, thereby catalyzing cyclic guanosine monophosphate (cGMP) synthesis. cGMP …
group, thereby catalyzing cyclic guanosine monophosphate (cGMP) synthesis. cGMP …